Baird raised the firm’s price target on Dentsply Sirona (XRAY) to $14 from $12 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona announces restructuring plan, expects $55M-$65M in charges
- Dentsply Sirona reports Q4 adjusted EPS 27c, consensus 29c
- Dentsply Sirona sees FY26 adjusted EPS $1.40-$1.50, consensus $1.50
- Dentsply Sirona Expands Board with Two New Directors
- Dentsply, Burkhart Dental Supply announce expanded distribution partnership